Pharmaceutical compositions
Described herein are pharmaceutical compositions comprising a LMWH preparation having at least one chain having a glycol split uronic acid residue (UG) in the preparation and uses thereof.
Momenta Pharmaceuticals, Inc.
A A A A A A A A A Y
A61K A61K A61P A61P A61P A61K A61P A61K A61P Y02A
inventional inventional inventional inventional inventional inventional inventional inventional inventional additional
Gary Kelly James
Mills Neelon Anderson